Bavarian Nordic A/S BVNKF:OTCPK

RT Quote | Exchange | USD
Last | 11:57 AM EDT
33.49quote price arrow down-0.25 (-0.74%)
Volume
632
52 week range
16.76 - 56.50
Loading...
  • Open32.33
  • Day High33.49
  • Day Low32.33
  • Prev Close33.74
  • 52 Week High56.50
  • 52 Week High Date09/08/21
  • 52 Week Low16.76
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap2,387M
  • Shares Out70.44M
  • 10 Day Average Volume1,548.56
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.3

KEY STATS

  • Open32.33
  • Day High33.49
  • Day Low32.33
  • Prev Close33.74
  • 52 Week High56.50
  • 52 Week High Date09/08/21
  • 52 Week Low16.76
  • 52 Week Low Date05/09/22
  • Market Cap2,387M
  • Shares Out70.44M
  • 10 Day Average Volume1,548.56
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.37
  • P/E (TTM)-24.53
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/24/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bavarian Nordic A/S

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2...
Gerard van Odijk M.D.
Chairman of the Board
Paul Chaplin Ph.D.
President, Chief Executive Officer
Russell Thirsk
Chief Operating Officer, Executive Vice President
Henrik Juuel
Executive Vice President, Chief Financial Officer
Jean-Christophe May Pharm.D.
Executive Vice President, Chief Commercial Officer
Address
Philip Heymans Alle 3
Hellerup
2900
Denmark